Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control.
about
CNTRICS final task selection: executive controlThe tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medicationsWhen doors of perception close: bottom-up models of disrupted cognition in schizophrenia.How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.Nonhuman primate model of schizophrenia using a noninvasive EEG method.N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.Chronic Ketamine Exposure Causes White Matter Microstructural Abnormalities in Adolescent Cynomolgus MonkeysSchizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia.Effects of ketamine on context-processing performance in monkeys: a new animal model of cognitive deficits in schizophreniaNeural correlates of executive control functions in the monkey.Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?CNTRICS imaging biomarker selections: Executive control paradigms.Toward a Cognitive Neural Prosthesis Using Focused Ultrasound.Simians in the Shape School: A comparative study of executive attention.The NMDAr antagonist ketamine interferes with manipulation of information for transitive inference reasoning in non-human primates.N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.Correlates of stimulus-response congruence in the posterior parietal cortex.Extensive practice does not eliminate human switch costs.
P2860
Q24651882-32257234-CDAD-4BFB-8926-46F816A0F974Q28270728-53279F6D-DEF2-437A-AEE4-AE92897A917FQ30406872-10D80E18-B43E-4DC2-A7E4-68F5EB6FA21CQ30439924-1567BCBA-8A38-4FAE-9201-45E62FACFBE2Q30448209-68CED3D8-E9D4-4287-9ED4-2376371DE913Q30474021-766715D7-7B4A-4B1B-8528-70B728FDDD85Q30758231-19267CAF-6B9D-4704-833C-F2E9A48CDEB5Q33705240-DFAA2374-7340-4127-8600-6BDD6A9D89FCQ33890117-626A523E-91F6-4637-8329-C81B812715F2Q37172725-D73F6B27-A672-4068-B0D8-FCEB92475B54Q37441994-15B6B9A7-B33B-4F66-8A89-537152E70F85Q37518251-063623DE-05B1-40F8-801A-1903B2E76E3CQ37960443-012853E9-EE80-408D-9A44-975AAED6F126Q46164607-2EAEA227-7B28-49DA-8933-2E8351BE164FQ47177989-08FB465E-68DB-4FB6-8893-248E7A68863BQ47855640-5026506C-959A-4525-B75C-C0303D645A11Q47954162-F126AC43-D23C-47AC-AE1C-C623C0BA83AAQ48284492-2CAC40E1-DED7-48B7-8493-835F36C8D757Q51972755-F946BA01-BCF4-4C5F-A8D8-2054C50D6872
P2860
Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effects of the NMDA antagonist ...... airments of executive control.
@en
Effects of the NMDA antagonist ...... airments of executive control.
@nl
type
label
Effects of the NMDA antagonist ...... airments of executive control.
@en
Effects of the NMDA antagonist ...... airments of executive control.
@nl
prefLabel
Effects of the NMDA antagonist ...... airments of executive control.
@en
Effects of the NMDA antagonist ...... airments of executive control.
@nl
P2860
P356
P1476
Effects of the NMDA antagonist ...... airments of executive control.
@en
P2093
Gijsbert Stoet
Lawrence H Snyder
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300930
P407
P577
2005-10-05T00:00:00Z